Citation

Vazquez M., Kaila N., Strohbach J., Trzupek J., Brown M., Flanagan M., Mitton-Fry M., Johnson T., TenBrink R., Arnold E., Basak A., Heasley S., Kwon S., Langille J., Parikh M., Griffin S., Casavant J., Duclos B., Fenwick A., Harris T., Han S., Caspers N., Dowty M., Yang X., Banker M., Hegen M., Symanowicz P., Li L., Wang L., Lin T., Jussif J., Clark J., Telliez J., Robinson R., Unwalla R.: Identification of <i>N</i>-{<i>cis</i>-3-[Methyl(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases. Journal of Medicinal Chemistry, Volume 61 (3), 2018

Authors

Michael L. Vazquez, Neelu Kaila, Joseph W. Strohbach, John D. Trzupek, Matthew F. Brown, Mark E. Flanagan, Mark J. Mitton-Fry, Timothy A. Johnson, Ruth E. TenBrink, Eric P. Arnold, Arindrajit Basak, Steven E. Heasley, Soojin Kwon, Jonathan Langille, Mihir D. Parikh, Sarah H. Griffin, Jeffrey M. Casavant, Brian A. Duclos, Ashley E. Fenwick, Thomas M. Harris, Seungil Han, Nicole Caspers, Martin E. Dowty, Xin Yang, Mary Ellen Banker, Martin Hegen, Peter T. Symanowicz, Li Li, Lu Wang, Tsung H. Lin, Jason Jussif, James D. Clark, Jean-Baptiste Telliez, Ralph P. Robinson, Ray Unwalla

Journal

Journal of Medicinal Chemistry

Year

2018

DOI

10.1021/acs.jmedchem.7b01598

Machine-readable

REST APIRDF